DurAVR™ THV: The First-In-Class Biomimetic TAVR to Restore Normal Aortic Flow Hemodynamics-FIH Study Results
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; Alleviant Medical; Cardiovalve; Abbott; Vdyne
- Non-Employed Chief Medical Officer - Anteris
- Equity/Stock(s)/Options - Alleviant Medical; XDot; V2V